Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective,Multicenter, Single-arm Clinical Trial to Evaluate Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System

NCT04744857 is registered in ClinicalTrials.gov with Peijia Medical Technology (Suzhou) Co., Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04744857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective,Multicenter, Single-arm Clinical Trial to Evaluate Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System
Lead sponsor
Peijia Medical Technology (Suzhou) Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
December 13, 2019
Completion date
October 16, 2020
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis